Ignite Creation Date:
2024-05-06 @ 2:58 PM
Last Modification Date:
2024-10-26 @ 1:40 PM
Study NCT ID:
NCT04484935
Status:
COMPLETED
Last Update Posted:
2023-11-15
First Post:
2020-06-30
Brief Title:
Evaluate the Safety and Tolerability for Nirsevimab in Immunocompromised Children
Sponsor:
Organization:
AstraZeneca